HYLORIS PHARMACEUTIC

HYL
Real-time Quote. Real-time  - 12/02 11:21:02 am
15.15EUR -0.66%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Other Pharmaceuticals
Hyloris Pharmaceuticals is a Belgium-based specialty pharmaceutical company. Its focus is on re-engineering cardiovascular products. Additionally, it also further develops and improves already-approved pharmaceuticals and established products, creating new and different solutions. The Company’s diverse product-development portfolio spans a wide range of therapeutic indications and dosage forms.
Sales per Business
20192020
Pharmaceuticals0.18194.5%0.18100%
EUR in Million
Sales per region
20192020
Belgium0.18194.5%0.18100%
EUR in Million
Managers
Name Title
Stijn van Rompay Chief Executive Officer & Executive Director
Jean-Luc Vandebroek Chief Financial Officer
Stefan Yee Chairman
Dietmar Aichhorn Chief Operating Officer
Marc Foidart Independent Director
Carolyn J. Myers Independent Director
James Charles Gale Independent Director
Chris Buyse Independent Director
Thomas Jacobsen Director & Chief Business Development Officer
Leon van Rompay Non-Executive Director
Shareholders
Name Equities %
Stijn van Rompay 6,824,304 26.4%
Thomas Jacobsen 3,504,089 13.6%
Bart Versluys 1,728,203 6.69%
Nick Reunbrouck 1,610,184 6.23%
Pieter van Rompay 915,000 3.54%
Saffelberg Investments NV 824,060 3.19%
Edward J. Maloney 428,828 1.66%
Mandarine Gestion SA 65,000 0.25%
Koenraad van der Elst 27,443 0.11%
SSgA Funds Management, Inc. 284 0.0011%
Company contact information
Boulevard Gustave Kleyer 17
BE-4000 Rocourt, Liège


Phone : +32 4346 02 07
Fax :
web site : http://www.hyloris.com
Markets and indexes
- Compartiment B
- BEL Small / PEA
Stock Exchange Codes
- Reuters Code :  HYL.BX
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
HYLORIS PHARMACEUTICALS SA60.53%446
JOHNSON & JOHNSON0.44%416 161
ROCHE HOLDING AG18.38%343 323
PFIZER, INC.48.55%306 912
NOVO NORDISK A/S66.91%247 444
ELI LILLY AND COMPANY47.55%225 859
ABBVIE INC.8.18%204 915
MERCK & CO., INC.-9.00%188 031
NOVARTIS AG-11.25%180 565
ASTRAZENECA PLC13.52%171 528
SANOFI9.07%122 030
BRISTOL-MYERS SQUIBB COMPANY-11.41%121 969
AMGEN INC.-13.50%113 104
GLAXOSMITHKLINE PLC14.84%102 790
CHUGAI PHARMACEUTICAL CO., LTD.-33.40%52 902
JIANGSU HENGRUI MEDICINE CO., LTD.-47.18%50 537
BAYER AG-5.78%50 479
DAIICHI SANKYO COMPANY, LIMITED-19.69%48 101
TAKEDA PHARMACEUTICAL COMPANY LIMITED-19.49%41 547
ASTELLAS PHARMA INC.11.29%28 790
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY44.16%23 918
Brand Portfolio
» More brands of Hyloris Pharmaceuticals SA